HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

'FDA' Link In Rodan + Fields Prop 65 Warning Now Goes To The Agency

This article was originally published in The Rose Sheet

Executive Summary

A link for FDA information included in Prop 65 warnings for Rodan & Fields benzophenone products went an industry site, the Environmental Working Group found. The firm replaced the link with one to FDA’s site, saying it used the industry website because it was more consumer friendly.

You may also be interested in...



Rodan + Fields Concealed Prostaglandin Risks From Lash Boost Users – Class Action

Marketers of cosmetic lash enhancers that haven’t abandoned prostaglandin analogs in favor of peptides or botanical extracts should take heed of a proposed class action against Rodan + Fields in California’s Northern District. Plaintiffs say they would not have purchased the firm’s Lash Boost and suffered alleged adverse effects if they’d been properly informed about product risks.

Rep. Pallone Keeps After Cosmetics; Edgewell Acquires Jack Black; Coty On Amazon Echo; News In Brief

Jack Black will join Schick razors, Bulldog skin care and Banana Boat sunscreens in Edgewell's brand portfolio; Congressman Pallone wants FDA to investigate Rodan + Fields. More cosmetics news in brief.

Rep. Pallone's Push For Cosmetics Reform Falls Flat During OTC Monograph Bill Markup

The New Jersey Democrat introduced multiple cosmetics-related amendments during the House Health Subcommittee's markup of draft OTC monograph reform legislation. While ultimately nothing came of the proposed measures, it's clear that Pallone remains intent on updating cosmetics regulations to require facility registration, adverse event reporting and good manufacturing practices, among other aims.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS121422

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel